Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Inovio Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +5 vs. Q4 2024
- Shares held
- 13.6M
- +300.0K (+2.3%) vs. Q4 2024
- Total value
- $22.2M
- −$2.18M (−9.0%) vs. Q4 2024
- New holders
- 18
- 33 more added
- Sold out
- 13
- 27 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $36.1M |
| Q1 2026 | 99 | $54.6M |
| Q4 2025 | 101 | $57.5M |
| Q3 2025 | 99 | $48.4M |
| Q2 2025 | 103 | $20.7M |
| Q1 2025 | 108 | $22.2M |
| Q4 2024 | 105 | $24.4M |
| Q3 2024 | 98 | $49.5M |
| Q2 2024 | 96 | $65.1M |
| Q1 2024 | 89 | $56.4M |
| Q4 2023 | 116 | $25.7M |
| Q3 2023 | 127 | $21.6M |
| Q2 2023 | 135 | $32.1M |
| Q1 2023 | 177 | $99.8M |
| Q4 2022 | 186 | $198.5M |
| Q3 2022 | 183 | $200.0M |
| Q2 2022 | 185 | $196.2M |
| Q1 2022 | 201 | $330.4M |
| Q4 2021 | 209 | $428.9M |
| Q3 2021 | 213 | $554.9M |
| Q2 2021 | 211 | $683.1M |
| Q1 2021 | 219 | $693.7M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Inovio Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 465,778 | $759.2K | 0.00% | +246,721+112.6% | Added |
| State Street Corp | 514,148 | $838.1K | 0.00% | +9,840+2.0% | Added |
| Stonepine Capital Management, LLC | 518,331 | $844.9K | 0.98% | −531,669−50.6% | Reduced |
| Geode Capital Management, LLC | 846,803 | $1.38M | 0.00% | +218,298+34.7% | Added |
| Bank of America Corp | 1,304,987 | $2.13M | 0.00% | +664,000+103.6% | Added |
| Vanguard Group Inc | 2,028,960 | $3.31M | 0.00% | +355,372+21.2% | Added |
| BlackRock, Inc. | 2,318,480 | $3.78M | 0.00% | +409,969+21.5% | Added |
| Deep Track Capital, LP | 3,119,162 | $5.08M | 0.16% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −654,115−100.0% | Sold out |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −97,400−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −65,669−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −62,567−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −51,255−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −35,431−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,728−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −16,906−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,502−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −193−100.0% | Sold out |
| Wingate Wealth Advisors, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Wood Tarver Financial Group, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Householder Group Estate & Retirement Specialist, LLC | – | – | – | – | Not filed |